Publicaciones en las que colabora con Julio Ponce García (65)

2017

  1. Decreased esophageal sensitivity to acid in morbidly obese patients: A cause for concern?

    Gut and Liver, Vol. 11, Núm. 3, pp. 358-362

2016

  1. Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and risk factors for esophagitis in Spain: A cross-sectional study)

    United European Gastroenterology Journal, Vol. 4, Núm. 2, pp. 229-235

2014

  1. Small intestinal bacterial overgrowth in inactive Crohn's disease: Influence of thiopurine and biological treatment

    World Journal of Gastroenterology, Vol. 20, Núm. 38, pp. 13999-14003

2013

  1. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome

    FEMS Microbiology Ecology, Vol. 86, Núm. 3, pp. 581-589

2012

  1. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome

    Environmental Microbiology Reports, Vol. 4, Núm. 2, pp. 242-247

  2. Structured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: Pooled analysis of five cluster-randomised European studies

    International Journal of Clinical Practice, Vol. 66, Núm. 9, pp. 897-905

2011

  1. High prevalence of heartburn and low acid sensitivity in patients with idiopathic achalasia

    Digestive Diseases and Sciences, Vol. 56, Núm. 3, pp. 773-776

  2. Structured management strategy versus usual care for gastroesophageal reflux disease: Rationale for pooled analysis of five European cluster-randomized trials

    Therapeutic Advances in Gastroenterology, Vol. 4, Núm. 1, pp. 11-26

2010

  1. Disease-specific health-related quality of life in patients with esophageal achalasia before and after therapy

    Neurogastroenterology and Motility, Vol. 22, Núm. 7, pp. 739-745

  2. The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients

    BMC Gastroenterology, Vol. 10

2009

  1. Outcome of non-variceal acute upper gastrointestinal bleeding in patients with antithrombotic therapy

    Digestion, Vol. 80, Núm. 2, pp. 89-94

2008

  1. Constipation during pregnancy: A longitudinal survey based on self-reported symptoms and the Rome II criteria

    European Journal of Gastroenterology and Hepatology, Vol. 20, Núm. 1, pp. 56-61

  2. Lesser known aspects of gastroesophageal reflux disease: Non-acid reflux and functional pyrosis

    Gastroenterologia y Hepatologia, Vol. 31, Núm. 8, pp. 522-529

2007

  1. Swallowing disorders: A challenge for the gastroenterologist

    Gastroenterologia y Hepatologia, Vol. 30, Núm. 8, pp. 487-497

2006

  1. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients

    Obesity, Vol. 14, Núm. 4, pp. 696-700

2004

  1. Factores que influyen en la decisión de administrar corticoides sistémicos en la enfermedad de Crohn

    Gastroenterologia y Hepatologia, Vol. 27, Núm. 8, pp. 444-449

  2. On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: Effectiveness, health-related quality of life, and patient satisfaction

    Digestive Diseases and Sciences, Vol. 49, Núm. 6, pp. 931-936

  3. Outcome of patients with nonstenotic, nonfistulizing Crohn's disease

    Digestive Diseases and Sciences, Vol. 49, Núm. 11-12, pp. 1771-1776

  4. Prevalence of Constipation: Agreement among Several Criteria and Evaluation of the Diagnostic Accuracy of Qualifying Symptoms and Self-reported Definition in a Population-based Survey in Spain

    American Journal of Epidemiology, Vol. 159, Núm. 5, pp. 520-526

  5. Quantitative cholescintigraphy and bile abnormalities in patients with acalculous biliary pain

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Núm. 8, pp. 1160-1165